Blase Polite, MD, associate professor of medicine and the executive director for accountable care at the University of Chicago, discusses why he chose to focus on the state of the Oncology Care Model at the April 25 meeting of the Institute for Value-Based Medicine.
Blase Polite, MD, associate professor of medicine and the executive director for accountable care at the University of Chicago, discusses why he chose to focus on the state of the Oncology Care Model at the April 25 meeting of the Institute for Value-Based Medicine.
Transcript:
Why did you want to focus on the state of the [Oncology Care Model] OCM at this meeting of the Institute for Value-Based Medicine?
Well, I think we’re at an inflection point or a crossroads in the OCM right now. We know that Medicare and [the Center for Medicare and Medicaid Innovation] CMMI are looking to develop the next model—what they’re I think calling OCM Plus–and I think this is an important time that those of us in the community who have had experience with the OCM and have been thinking about this for the past several years really have to start putting in our input into what we think has worked, and what we think has not worked with the OCM. So, I was hoping to bring some people who I believe are thought leaders, both within understanding the OCM, individuals who are thinking about different models that we think accomplish the same mission that CMS is trying to do, and I think some very forward thinking private payers who are beginning to look at how you get to value-based care in the oncology space. So, I was hoping that from this we’ll generate some ideas that eventually the CMS folks will listen to as they put together the next version of the model.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More